Literature DB >> 17766469

S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway.

Shin Chet Chuah1, Philip K Moore, Yi Zhun Zhu.   

Abstract

S-allylcysteine (SAC) is an organosulfur-containing compound derived from garlic. Studies have shown that garlic is beneficial in the treatment of cardiovascular diseases. This study aims to elucidate if SAC is responsible for this cardioprotection using acute myocardial infarction (AMI) rat models. In addition, we hypothesized that SAC may mediate cardioprotection via a hydrogen sulfide (H(2)S)-related pathway. Rats were pretreated with saline, SAC (50 mg x kg(-1) x day(-1)), SAC + propagylglycine (PAG; 50 mg + 10 mg x kg(-1) x day(-1)) or PAG (10 mg x kg(-1) x day(-1)) for 7 days before AMI induction and killed 48 h after. Our results showed that SAC significantly lowered mortality (12.5% vs. 33.3%, P < 0.05) and reduced infarct size. SAC + PAG- and PAG-treated rats had larger infarct sizes than controls (60.9 +/- 0.01 and 62.0 +/- 0.03%, respectively, vs. 50.0 +/- 0.03%; P < 0.05). Pretreatment with SAC did not affect BP, but BP was significantly elevated in SAC + PAG and PAG-treated groups (P < 0.05). In addition, plasma H(2)S levels and left ventricular cystathionine-gamma-lyase (CSE) activities were analyzed to investigate the involvement of H(2)S. CSE is the enzyme responsible for H(2)S production in the heart. SAC increased left ventricular CSE activity in AMI rats (2.75 +/- 0.34 vs. 1.23 +/- 0.16 micromol x g protein(-1) x h(-1); P < 0.01). SAC + PAG-treated rats had significantly lower CSE activity compared with the SAC-treated group (1.22 +/- 0.27 vs. 2.75 +/- 0.34 micromol x g protein(-1) x h(-1); P < 0.05). Similarly, SAC-treated rats had higher plasma H(2)S concentration compared with controls and the SAC + PAG-treated group. Protein expression studies revealed that SAC upregulated CSE expression (1.1-fold of control; P < 0.05), whereas SAC + PAG and PAG downregulated its expression (0.88-fold of control in both groups; P < 0.005). In conclusion, our study provides novel evidence that SAC is protective in myocardial infarction via an H(2)S-related pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766469     DOI: 10.1152/ajpheart.00853.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  40 in total

Review 1.  Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications.

Authors:  Csaba Szabo
Journal:  Antioxid Redox Signal       Date:  2012-01-30       Impact factor: 8.401

2.  Generation of DNA-damaging reactive oxygen species via the autoxidation of hydrogen sulfide under physiologically relevant conditions: chemistry relevant to both the genotoxic and cell signaling properties of H(2)S.

Authors:  Marjorie Hoffman; Anuruddha Rajapakse; Xiulong Shen; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2012-06-04       Impact factor: 3.739

3.  Cardioprotective effects of hydrogen sulfide.

Authors:  Gábor Szabó; Gábor Veres; Tamás Radovits; Domokos Gero; Katalin Módis; Christiane Miesel-Gröschel; Ferenc Horkay; Matthias Karck; Csaba Szabó
Journal:  Nitric Oxide       Date:  2010-11-19       Impact factor: 4.427

Review 4.  Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?

Authors:  Li Long Pan; Xin Hua Liu; Qi Hai Gong; He Bei Yang; Yi Zhun Zhu
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

5.  Garlic oil polysulfides: H2S- and O2-independent prooxidants in buffer and antioxidants in cells.

Authors:  Eric R DeLeon; Yan Gao; Evelyn Huang; Kenneth R Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-13       Impact factor: 3.619

6.  Development of hydrogen sulfide-based therapeutics for cardiovascular disease.

Authors:  Benjamin L Predmore; David J Lefer
Journal:  J Cardiovasc Transl Res       Date:  2010-07-14       Impact factor: 4.132

Review 7.  The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Tienush Rassaf; Rainer Schulz; Andreas Papapetropoulos; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-09-23       Impact factor: 8.739

8.  The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.

Authors:  Qian Ding; Yi-Zhun Zhu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Therapeutic application of hydrogen sulfide donors: the potential and challenges.

Authors:  Dan Wu; Qingxun Hu; Yizhun Zhu
Journal:  Front Med       Date:  2015-11-23       Impact factor: 4.592

10.  Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide.

Authors:  Michael A Insko; Thomas L Deckwerth; Paul Hill; Christopher F Toombs; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-05-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.